Patents by Inventor Libin Zhao

Libin Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230398571
    Abstract: A corrosion-resistant magnesium alloy with a multi-level protective coating, and to a preparation process thereof. The magnesium alloy with a multi-level protective coating comprises a magnesium alloy substrate and a multi-level protective coating. The multi-level protective coating comprises a micro-arc oxidation layer of magnesium alloy provided on the surface of the magnesium alloy substrate, an epoxy primer layer provided on the surface of the micro-arc oxidation layer of magnesium alloy, and a polyurethane topcoat layer provided on the surface of the epoxy primer layer. The magnesium alloy with a multi-level protective coating effectively integrates the excellent adhesion of the micro-arc oxidation layer and the excellent anti-corrosion effect of the organic coating.
    Type: Application
    Filed: January 3, 2022
    Publication date: December 14, 2023
    Applicant: The Boeing Company
    Inventors: Dingfei Zhang, Yuping Liu, Chao Miao, Hanxi Zhao, Libin Zhao
  • Patent number: 9072745
    Abstract: Provided is the use of a Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease, and particularly the use of the Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of stable angina type coronary heart disease and the reduction of serious vascular events.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: July 7, 2015
    Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD
    Inventors: Xijun Yan, Naifeng Wu, Kaijing Yan, He Sun, Zhixin Guo, Guoguang Zhu, Weiwei Liu, Libin Zhao, Ruizhi Luo
  • Publication number: 20130196005
    Abstract: Provided is the use of a Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease, and particularly the use of the Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of stable angina type coronary heart disease and the reduction of serious vascular events.
    Type: Application
    Filed: August 8, 2011
    Publication date: August 1, 2013
    Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Xijun Yan, Naifeng Wu, Kai Yan, He Sun, Zhixin Guo, Guoguang Zhu, Weiwei Liu, Libin Zhao, Ruizhi Luo
  • Patent number: 6872869
    Abstract: The present invention provides a method for establishing an expression system of spider dragline silk gene in Bombyx mori. The rate of transformation is about 0.5-1%. In the silk protein produced by the transgenic Bombyx mori obtained by the method of the present invention, the spider dragline silk gene product account for 30% of the total silk proteins.
    Type: Grant
    Filed: October 4, 2001
    Date of Patent: March 29, 2005
    Assignee: Chengdu Tianchuang Bio-Tech Co., Ltd.
    Inventors: Tianyan Liu, Huifen Liu, Wei Li, Libin Zhao
  • Publication number: 20020137211
    Abstract: The present invention provides a method for establishing an expression system of spider dragline silk gene in Bombyx mori. The rate of transformation is about 0.5-1%. In the silk protein produced by the transgenic Bombyx mori obtained by the method of the present invention, the spider dragline silk gene product account for 30% of the total silk proteins.
    Type: Application
    Filed: October 4, 2001
    Publication date: September 26, 2002
    Applicant: Sichuan University Tianyou Biologic Engineering Co. LTD.
    Inventors: Tianyan Liu, Huifen Liu, Wei Li, Libin Zhao